HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Brian F Gage Selected Research

Warfarin (Coumadin)

3/2012Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.
7/2010Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke.
6/2010Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).
1/2009Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.
6/2008Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.
4/2006Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.
9/2005Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.
6/2005Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall.
4/2005Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.
2/2005Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Brian F Gage Research Topics

Disease

11Hemorrhage
03/2012 - 09/2002
6Stroke (Strokes)
07/2010 - 02/2005
5Atrial Fibrillation
07/2010 - 02/2005
3Myocardial Infarction
03/2012 - 08/2003
2Thromboembolism
06/2010 - 09/2002
2Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2005 - 02/2005
1Aortic Valve Stenosis (Aortic Stenosis)
05/2012
1Hypotension (Low Blood Pressure)
05/2012
1Inflammation
06/2005
1Cardiac Arrhythmias (Arrythmia)
04/2005
1Syncope (Fainting)
04/2005
1Cardiomyopathies (Cardiomyopathy)
04/2005
1Heart Failure
01/2005

Drug/Important Bio-Agent (IBA)

14Warfarin (Coumadin)FDA LinkGeneric
03/2012 - 09/2002
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2005 - 02/2005
1sildenafil (Viagra)FDA Link
05/2012
1Phosphodiesterase 5 InhibitorsIBA
05/2012
1Heparin (Liquaemin)FDA LinkGeneric
03/2012
1clopidogrel (Plavix)FDA Link
03/2012
1AnticoagulantsIBA
03/2012
1Glycoproteins (Glycoprotein)IBA
03/2012
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2010
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2010
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2010
1Complement System Proteins (Complement)IBA
04/2009
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
04/2005
1ximelagatran (Exanta)IBA
02/2005
1Hemoglobins (Hemoglobin)IBA
08/2003
1NitrogenIBA
08/2003
1Urea (Carbamide)FDA LinkGeneric
08/2003
1Calcium Channels (Calcium Channel)IBA
08/2003
1CoumarinsIBA
09/2002
1coumarinIBA
09/2002

Therapy/Procedure

2Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
04/2005 - 01/2005
1Lung Transplantation
06/2005
1Complementary Therapies (Alternative Medicine)
02/2005